Rekah Pharmaceutical Industry Ltd. (REKA.TA)
ILA 1176.0
(-1.26%)
ILA 1176.0
(-1.26%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 321.66 Million ILS | 10.01% |
| 2022 | 292.39 Million ILS | 10.78% |
| 2021 | 263.95 Million ILS | -0.57% |
| 2020 | 265.47 Million ILS | 35.1% |
| 2019 | 196.49 Million ILS | -5.45% |
| 2018 | 207.82 Million ILS | -0.17% |
| 2017 | 208.18 Million ILS | -4.67% |
| 2016 | 218.38 Million ILS | -16.78% |
| 2015 | 262.42 Million ILS | 21.29% |
| 2014 | 216.37 Million ILS | -19.87% |
| 2013 | 270.03 Million ILS | 0.01% |
| 2012 | 269.99 Million ILS | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 89.67 Million ILS | 4.22% |
| 2024 Q2 | 68.69 Million ILS | -23.4% |
| 2023 Q2 | 76.66 Million ILS | -2.96% |
| 2023 Q1 | 79 Million ILS | -0.84% |
| 2023 Q4 | 86.04 Million ILS | 7.62% |
| 2023 FY | 321.66 Million ILS | 10.01% |
| 2023 Q3 | 79.95 Million ILS | 4.3% |
| 2022 Q3 | 73.41 Million ILS | 9.82% |
| 2022 FY | 292.39 Million ILS | 10.78% |
| 2022 Q1 | 72.46 Million ILS | -2.33% |
| 2022 Q2 | 66.84 Million ILS | -7.75% |
| 2022 Q4 | 79.67 Million ILS | 8.52% |
| 2021 Q1 | 64.67 Million ILS | -10.56% |
| 2021 Q4 | 74.19 Million ILS | 19.7% |
| 2021 Q3 | 61.98 Million ILS | -1.77% |
| 2021 FY | 263.95 Million ILS | -0.57% |
| 2021 Q2 | 63.09 Million ILS | -2.44% |
| 2020 Q2 | 53.18 Million ILS | -20.91% |
| 2020 Q1 | 67.24 Million ILS | 44.67% |
| 2020 FY | 265.47 Million ILS | 35.1% |
| 2020 Q4 | 72.31 Million ILS | -0.55% |
| 2020 Q3 | 72.72 Million ILS | 36.73% |
| 2019 Q1 | 50.69 Million ILS | -5.33% |
| 2019 FY | 196.49 Million ILS | -5.45% |
| 2019 Q4 | 46.48 Million ILS | -14.75% |
| 2019 Q3 | 54.52 Million ILS | 16.28% |
| 2019 Q2 | 46.89 Million ILS | -7.5% |
| 2018 Q4 | 53.54 Million ILS | 5.52% |
| 2018 FY | 207.82 Million ILS | -0.17% |
| 2018 Q1 | 53.61 Million ILS | -1.53% |
| 2018 Q2 | 49.91 Million ILS | -6.9% |
| 2018 Q3 | 50.74 Million ILS | 1.66% |
| 2017 FY | 208.18 Million ILS | -4.67% |
| 2017 Q1 | 51.08 Million ILS | 1.16% |
| 2017 Q2 | 50.21 Million ILS | -1.71% |
| 2017 Q3 | 52.43 Million ILS | 4.43% |
| 2017 Q4 | 54.45 Million ILS | 3.85% |
| 2016 Q2 | 50.88 Million ILS | -16.01% |
| 2016 FY | 218.38 Million ILS | -16.78% |
| 2016 Q1 | 60.57 Million ILS | 246.35% |
| 2016 Q4 | 50.5 Million ILS | -10.5% |
| 2016 Q3 | 56.42 Million ILS | 10.9% |
| 2015 FY | 262.42 Million ILS | 21.29% |
| 2015 Q4 | 17.49 Million ILS | -73.55% |
| 2015 Q3 | 66.11 Million ILS | 9.77% |
| 2015 Q2 | 60.22 Million ILS | -8.84% |
| 2015 Q1 | 66.06 Million ILS | 1.38% |
| 2014 Q2 | 66.26 Million ILS | -6.68% |
| 2014 Q4 | 65.16 Million ILS | -3.54% |
| 2014 FY | 216.37 Million ILS | -19.87% |
| 2014 Q3 | 67.55 Million ILS | 1.95% |
| 2014 Q1 | 71 Million ILS | 4.44% |
| 2013 FY | 270.03 Million ILS | 0.01% |
| 2013 Q2 | 70.87 Million ILS | 5.25% |
| 2013 Q3 | 63.83 Million ILS | -9.93% |
| 2013 Q4 | 67.99 Million ILS | 6.51% |
| 2013 Q1 | 67.33 Million ILS | -5.29% |
| 2012 Q4 | 71.1 Million ILS | 4.36% |
| 2012 Q3 | 68.13 Million ILS | 0.0% |
| 2012 FY | 269.99 Million ILS | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cannabotech LTD | 1.21 Million ILA | -26287.449% |